CERUS CORP
For the period ended Apr 25, 2024. Filed Apr 26, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 25, 2024 · Filed Apr 26, 2024
Contents
SUMMARY COMPENSATION TABLE
The following table sets forth certain summary information for the year indicated with respect to the compensation earned by our principal executive officer, our principal financial officer and our three other most highly compensated executive officers at December 31, 2023. These individuals represent the Company’s NEOs.
SUMMARY COMPENSATION TABLE
| Name and Principal Position · Year · Salary · Stock Awards · Option Awards · Non-Equity Incentive Plan Compensation · All Other Compensation · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| ($) | ($)(1) | ($) | ($)(2) | ($) | ($) | |||
| William M. Greenman | 2023 | 763,750 | 2,624,850 | — | 269,500 | 2,372 | (3) | 3,660,472 |
| President and | 2022 | 732,083 | 2,505,600 | 1,427,844 | 595,700 | 2,372 | 5,263,599 | |
| Chief Executive Officer | 2021 | 696,375 | 2,529,760 | 1,406,304 | 547,560 | 2,372 | 5,182,371 | |
| Kevin D. Green | 2023 | 484,208 | 854,042 | — | 122,030 | 1,292 | (4) | 1,461,572 |
| Vice President, Finance | 2022 | 464,689 | 806,400 | 459,536 | 269,873 | 13,930 | 2,014,428 | |
| and Chief Financial Officer | 2021 | 443,414 | 847,600 | 481,104 | 253,446 | 1.292 | 2,026,856 | |
| Vivek Jayaraman | 2023 | 544,008 | 1,093,600 | — | 150,811 | 1,860 | (5) | 1,790,279 |
| Chief Operating Officer | 2022 | 522,079 | 1,036,800 | 590,832 | 333,524 | 6,067 | 2,489,302 | |
| 2021 | 497,218 | 978,000 | 555,120 | 346,518 | 1,560 | 2,378,416 | ||
| Richard Benjamin | 2023 | 489,126 | 738,600 | — | 110,942 | 3,614 | (6) | 1,342,282 |
| Chief Medical Officer | 2022 | 470,773 | 604,800 | 344,652 | 245,353 | 3,614 | 1,669,192 | |
| 2021 | 455,300 | 652,000 | 370,080 | 259,731 | 3,614 | 1,740,725 | ||
| Chrystal Jensen | 2023 | 464,776 | 738,600 | — | 105,419 | 1,292 | (7) | 1,310,087 |
| Chief Legal Officer and | 2022 | 446,900 | 604,800 | 344,652 | 233,139 | 12,122 | 1,641,613 | |
| General Counsel | ||||||||
(1) Amounts included in this column for 2023 represent the aggregate grant date fair value of RSU awards and PRSU awards for 2023 calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation – Stock Compensation, or Topic 718, using the assumptions discussed in Note 12 to our financial statements for the fiscal year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2024. The grant date fair value of each RSU award is measured based on the closing price of our common stock on the date of grant. The PRSU awards, in order to vest, require achievement of certain performance-based vesting conditions, including revenue and clinical trial enrollment goals, during a three-year performance period. The grant date fair value of these PRSU awards was determined in accordance with Topic 718 based upon the probable outcome of the performance-based vesting conditions underlying such awards. Assuming the highest level of performance is achieved, the aggregate grant date fair value of such PRSU awards would be $1,211,210, $400,171, $503,360, $346,060 and $346,060, for Messrs. Greenman, Green, Jayaraman and Benjamin and Ms. Jensen, respectively. These amounts do not reflect whether the NEO has actually realized or will realize a financial benefit from the awards upon the vesting of the granted stock awards, or the sale of the shares underlying such stock awards. For additional detail, see the discussion in the section entitled “2023 Long-Term Incentive Compensation” within the “Compensation Discussion and Analysis” section of this proxy statement.
(2) Amounts included in this column represent the cash bonus paid under our Bonus Plan. For additional detail with respect to the amount included for 2023, see the discussion in the section entitled, “Bonus Plan for 2023” within the “Compensation Discussion and Analysis” section of this proxy statement.
(3) Represents group-term life insurance premiums in the amount of $2,322 and a cell phone accessory stipend of $50.
(4) Represents group-term life insurance premiums in the amount of $1,242 and a cell phone accessory stipend of $50.
(5) Represents group-term life insurance premiums in the amount of $810 and a remote employee stipend of $1,050.
(6) Represents group-term life insurance premiums in the amount of $3,564 and a cell phone accessory stipend of $50.
(7) Represents group-term life insurance premiums in the amount of $1,242 and a cell phone accessory stipend of $50.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.